This JM Smucker Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
at www.benzinga.com (Wed, 11-Mar 7:47 AM)
at www.benzinga.com (Tue, 10-Mar 8:17 AM)
uniQure: Regulatory Shift and AMT-130 Outlook Drive Reaffirmed Buy Rating and $70 Target
at www.tipranks.com (Tue, 10-Mar 6:25 AM)
Market Chameleon (Mon, 9-Mar 10:34 AM)
U.S. Chess Champion Sitting on Huge 42.33% uniQure (QURE) Loss
at www.tipranks.com (Mon, 9-Mar 12:21 PM)
Biotech firm stocks rise on FDA vaccine head’s exit
at seekingalpha.com (Mon, 9-Mar 9:40 AM)
uniQure surges following departure of key FDA official
at seekingalpha.com (Mon, 9-Mar 9:01 AM)
FDA vaccine chief to leave the agency again
at seekingalpha.com (Sat, 7-Mar 7:41 AM)
uniQure Faces FDA Setback on AMT-130 for Huntington’s Disease—What’s Next for the Program?
Market Chameleon (Mon, 2-Mar 7:09 AM)
QURE Pre-Earnings History Points to a Sharp Rally
Market Chameleon (Tue, 24-Feb 11:00 AM)
FDA Meeting Scheduled Could Accelerate Approval Path for uniQure’s Huntington’s Disease Gene Therapy
Market Chameleon (Fri, 9-Jan 7:28 AM)
